Will the Reckitt share price finally recover after announcing a major shakeup?

The Reckitt share price has climbed slightly higher today after somewhat positive news. But I wonder if it’s enough to ignite a full recovery.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Middle-aged white man wearing glasses, staring into space over the top of his laptop in a coffee shop

Image source: Getty Images

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

The Reckitt Benckiser (LSE:RKT) share price is up 0.8% today after mixed first-half earnings results caused some volatility. It briefly spiked to £45.80 before retracing back towards yesterday’s level of around £44.

The fast-moving consumer goods (FMCG) company has had a tough year, marred by reporting issues, lawsuits, and a tornado. It’s down 20% since the new year, dragging out an eight-year-long decline that has seen the price almost halve in value. 

Way back in June 2017, it hit an all-time high of £80 following a 20-year-long rally that saw the price grow 780%.

So are the good times over or can this mega-cap FCMG relive the glory days?

Major shakeup

This year’s string of bad luck seems to have ignited a fire under the seats of those in charge. Along with today’s report, Reckitt announced a major overhaul to the business.

It now plans to sell its £1.9bn home care portfolio and shift focus entirely to its health and hygiene product range. The home care range includes popular household names like Air Wick, Cillit Bang, and Mortein. Despite their popularity, the company deems them as “no longer core“, as opposed to other brands that “offer the best long-term opportunity for growth“.

It noted Strepsils, Nurofen, and Durex as more profitable brands.

Lack of nutrition

In addition to dropping home care, it’ll also offload its troubled Mead Johnson Nutrition business, which markets Enfamil and Nutramigen.

The share price tumbled earlier this year after Enfamil was blamed for the death of an infant in the US. A warehouse that manufactures and stores the product was later hit by a tornado, interrupting the supply chain.

Since the nutrition business only accounts for 15% of revenue, shareholders have been pressuring the group to sell it. The asset manager Flossbach von Storch, which owns 4.2% of Reckitt, feels nutrition doesn’t “really have a strong strategic fit“. The sentiment is echoed by another top 10 shareholder, Causeway Capital, saying it “doesn’t fit into their future”.

However, the business may be difficult to sell. Analysts estimate the total liability from the Enfamil litigation could reach as much as £8bn.

Forecast downgrade

Revenue was flat in Wednesday’s report and operating profit was down 4.9% to £1.7bn. Like-for-like net sales grew 0.8% but still missed analysts expectations. Much of the losses have been attributed to the tornado, although the company believes its comprehensive insurance will make up most of the £150m in lost revenue.

Based on the results, the group has lowered its full-year sales growth forecast for 2024 by 1%.

Despite the downgrade, today’s announcement was well received. Shareholders seem to be in agreement with the reorganisation efforts, feeling it’s a step in the right direction. The price has increased 8% since hitting a yearly low of £41.10 in April this year.

A slow recovery

For shareholders like me, it may be some time before we see profit again. The average 12-month price target of analysts evaluating the stock is around £53 — a 20% increase.

Prior to this year, the last time it traded that low was early 2015.

Although now looks like a good opportunity, I think the risk from the nutrition business is too high. If it manages to offload that efficiently, then I’ll consider buying more shares.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Mark Hartley has positions in Reckitt Benckiser Group Plc. The Motley Fool UK has recommended Reckitt Benckiser Group Plc. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Closeup ruffled American flag representing US stocks and shares
Investing Articles

2 UK stocks that could rise if Harris wins the Presidential election

Royston Wild believes these UK stocks could receive a bump if Kalama Harris wins the Presidency, giving their share prices…

Read more »

Investing Articles

After a 96% plunge, is buying more Aston Martin shares throwing good money after bad?

Just two weeks after buying Aston Martin shares Harvey Jones found himself nursing a painful loss. Yet after recent news…

Read more »

Investing Articles

After crashing 45% in October, should I buy this FTSE 250 share for my Stocks and Shares ISA?

Roland Head explains why he’s tempted to add this risky FTSE 250 turnaround share to his Stocks and Shares ISA…

Read more »

Investing Articles

Could I use a stock market crash to turn £20k into half a mil in just over a decade?

A stock market crash might sound terrifying to some but it can also present a once-in-a-lifetime opportunity to accumulate generational…

Read more »

Investing Articles

Recently released: October’s small-cap stock recommendation [PREMIUM PICKS]

We believe the UK small-cap market offers a myriad of opportunities across a wide range of different businesses and industries.

Read more »

Investing Articles

Here’s how a Stocks and Shares ISA and Lifetime ISA could supercharge my wealth!

Individual Savings Accounts (ISAs) can help UK share investors take their earnings to the next level. And their importance is…

Read more »

A person holding onto a fan of twenty pound notes
Investing Articles

A high-yield dividend ETF and an investment trust to consider this November!

Investors wanting to boost their passive income could benefit from investigating these high-yield funds and trusts, says Royston Wild.

Read more »

Investing Articles

2 of my favourite, cheap FTSE 100 growth shares this November!

These FTSE 100 growth shares could be great long-term picks to consider, reckons Royston Wild. At current prices he thinks…

Read more »